Topic - The European Medicines Agency

Related Stories

The European Medicines Agency has started a rolling review of Russia’s Sputnik V coronavirus vaccine

Associated Press

AstraZeneca/Oxford University vaccine is seen on a cooler before it is administered to health workers at Teaching Hospital in Kathmandu, Nepal, Wednesday, Jan. 27, 2021. Thousands of health workers lined up across Nepal to get the coronavirus vaccine Wednesday as the Himalayan nation began its campaign to get the population vaccinated within three months. Neighboring India gifted Nepal 1 million doses of the vaccine manufactured under license by the Serum Institute of India. (AP Photo/Niranjan Shrestha)

EU official: AstraZeneca pulls out of vaccine delivery talks

By Raf Casert - Associated Press

A person enters the European Medicines Agency in Amsterdam, Netherlands, Monday, Dec. 21, 2020, where the EMA's human medicines committee is holding an exceptional, fully virtual, meeting to conclude the evaluation of the Pfizer-BioNTech COVID-19 vaccine. (AP Photo/Peter Dejong)

EU greenlights COVID-19 vaccine after agency gives safety OK

By FRANK JORDANS and LORNE COOK - Associated Press

FILE - In this Tuesday, Dec. 8, 2020 file photo, a nurse holds a phial of the Pfizer-BioNTech COVID-19 vaccine at Guy's Hospital in London. As Canadians, Britons and Americans begin getting immunized with a German-developed vaccine against the coronavirus, pressure is building on the European Medicines Agency to approve the shot made by Pfizer Inc. and German company BioNTech. Those countries all approved the COVID-19 vaccine under emergency use rules, meaning it is an unlicensed product. But the EMA approval process for coronavirus vaccines is largely similar to the standard licensing procedure that would be granted to any new vaccine, only on an accelerated schedule. (AP Photo/Frank Augstein, Pool, File)

EXPLAINER: Why is the EU taking so long to OK vaccine?

Associated Press